PAR 3.28% 31.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-169

  1. 1,579 Posts.
    lightbulb Created with Sketch. 165
    If 800M shares gets us through the whole process
    to market Zilosul, instead of maybe what we
    were expecting (300-400M), it means our
    shares will be worth half of what we expected.
    Surely that is better then a deal where PAR is
    jammed into a grubby little agreement with a
    partner for say 10% of sales.

    I really don’t see why you think such a dilution
    would be the death of the company. I am not trying
    to be a smart arse. Genuinely would like to know.

    Most of us are way down on our initial purchases.
    From a personal point of view, I would not like to see
    such a dilution, as I am in no position to participate
    in such a CR. (I guess if instos stumped up at 43c,
    then they are likely to participate @ 20-25c),
    However, I think it is the lesser of the other evils
    we face. If we have not been able to make a deal
    during the past couple of years, then there is fat
    chance of a good deal now with the precarious
    financial position we face.




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
0.010(3.28%)
Mkt cap ! $106.6M
Open High Low Value Volume
31.5¢ 31.5¢ 31.5¢ $2.232K 7.087K

Buyers (Bids)

No. Vol. Price($)
3 69096 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 39618 4
View Market Depth
Last trade - 10.06am 18/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.